Upload

Dr Vincent Obaga NYANDORO, PhD

OffLine
Staff Information
PERSONAL DETAILS
Designation
Lecturer, Pharmaceutics
Department
Pharmaceutical Chemistry & Pharmaceutics
Section
Pharmaceutics
SUMMARY

Pharmacist, lecturer and researcher with expertise in pharmaceutics and drug delivery systems, including nanomedicine and formulation technology. Proven track record in undergraduate and postgraduate teaching, curriculum development, and academic leadership. Active researcher with 19 peer-reviewed publications and a history of securing research grants. Passionate about mentoring the next generation of pharmaceutical scientists.

Google Scholar
https://scholar.google.com/citations?hl=en&user=M4j9FdsAAAAJ
ResearchGate
https://www.researchgate.net/profile/Vincent-Nyandoro-3
ACADEMIC QUALIFICATIONS

2023- 2026: PhD in Pharmaceutics- University of KwaZulu-Natal, Durban, South Africa

2018-2019: Master of Science in Pharmaceutical Technology- Univeristy of Jos, Jos Plateau, Nigeria

2011-2016: Bachelor of Pharmacy- Kenyatta Univeristy, Nairobi, Kenya

PROFESSIONAL QUALIFICATIONS
  1. Capacity Strengthening Engagement and Mentorship (CaSE) Fellowship- Track 1: Introduction to Regulatory Practice, University of Wisconsin–Madison, USA (2024)
  2. Competency based education training, Kabarak University (2024)
  3. Scientific and Ethics Review Workshop, Kabarak University (2024)
  4. Bioethics and Animal Welfare Training, University of KwaZulu-Natal (2023)
  5. Intentional Teaching and Total Participation Techniques Workshop (2023)
  6. Pharmaceutical Systems Strengthening 101 Course (2022)
  7. Research Methods Certificate Course, CBEC-KEMRI (2021)
  8. Advanced Family Planning Workshop, JHPIEGO (2021)
  9. Leadership, Management and Governance for Health Systems Strengthening (2021)
  10. Tablet Development Workshop, University of Nairobi (2019)
FIELDS OF SPECIALIZATION

 

1. Drug formulation and delivery.

WORK EXPERIENCE

Kabarak University, Nakuru Kenya (January 2020 to present)

Lecturer in Pharmaceutics

  • Development of Master of Pharmacy in Pharmaceutical Manufacturing and Review of Bachelor of Pharmacy curriculum.
  • Carrying out research and supervising students’ research projects.
  • Teaching areas (Research Ethics; Cosmetology; current good manufacturing practices (cGMPs); Pharmaceutical calculations and compounding; Formulation of dosage forms; Pharmaceutical microbiology; Novel drug delivery systems; Biopharmaceutics, bioequivalence & pharmacokinetics; Pharmaceutical biotechnology)
  • Responsibilities and University service
    • Acting Head, Pharmaceutical Chemistry and Pharmaceutics department (May-Aug 2022, Jan-April 2026)
    • Acting Head, Preclinicals department (Jan-April 2021, Jan-Mar 2022, May-Aug 2026)
    • Industrial Attachment Coordinator (2021-present)
    • Member, University Curriculum committee (2025-present)
    • Member, University Online Teaching committee (Mar 2022-present)
    • Former Member, Outreach and Linkages Committee (Oct 2022- Oct 2024)
    • Former Member, Directorate of Excellence in Learning and Teaching Advisory Committee (Nov 2021- Oct 2022)

Kenya Methodist University, Meru Kenya (September-December 2019)

Assistant Lecturer in Pharmaceutics

  • Lecture planning, preparation and research

Ministry of Health, Kenya (March 2017- March 2018)

Pharmacist Intern

  • Experiential learning through working within a professional work setting (hospital, pharmaceutical industry and community pharmacy).
KEY PROJECTS

1. Novel drug delivery nanosystems for enhancing treatment of bacterial infections

2. Pharmaceutical excipients from agro-waste

RESEARCH INTERESTS
  • Pharmaceutical formulation and dosage form design
  • AI- and data-driven pharmaceutical product development
  • Biomaterials and novel pharmaceutical excipients
  • Cosmeceuticals and Nutraceuticals
LIST OF PUBLICATIONS
  1. Hassan, D., Nwabuife, J., Eze, E., Nyandoro, V., Murugesan, V., Sekhoacha, M., Govender, T. & Omolo, C. (2026). Engineering nanoplex platforms for enhanced transfection and gene expression in cancer therapy. Nanotechnology Reviews, 15(1), 20250331. https://doi.org/10.1515/ntrev-2025-0331
  2. Nyandoro, V. O., Omolo, C. A., Ismail, E. A., Tageldin, A., Gafar, M. A., Govender, J., & Govender, T. Novel lipid and ascorbyl stearate biomimetic vancomycin-loaded nanostructured lipid carrier therapy for bacterial infections and sepsis. RSC advances. https://doi.org/10.1039/d6ra01364c
  3. Nyandoro, V. O., Omolo, C. A., Tageldin, A., Ismail, E. A., Gafar, M. A., Nkambule, B. B., ... & Govender, T. (2026). Polyethyleneimine/Ascorbyl Stearate Nanocarrier Enhances Vancomycin Delivery and Demonstrates Antibacterial, Antioxidant, and Anti-inflammatory Activities in MRSA-induced Sepsis Model. Journal of Drug Delivery Science and Technology, 108639. https://doi.org/10.1016/j.jddst.2026.108639
  4. Tageldin, A., Omo lo, C. A., Nyandoro, V. O., Ismail, E. A., Gafar, M. A., Nkambule, B., ... & Govender, T. (2026). Dual-Targeting Sepsis-Associated Inflammation and Infection Using Linoleic Acid-Based Lipid-Polymer Hybrid Nanoparticles. Journal of Materials Chemistry B. https://doi.org/10.1039/D6TB00207B 
  5. Tageldin, A., Gafar, M. A., Ismail, E. A., Nyandoro, V. O., Elamin, G., Nkambule, B. B., ... & Omolo, C. A. (2026). A novel biomimetic and redox-responsive hybrid lipid polymer nanoparticle for targeting sepsis microenvironment and modulating inflammation. International Journal of Pharmaceutics, 126683. https://doi.org/10.1016/j.ijpharm.2026.126683
  6. Ismail, E. A., Tageldin, A., Gafar, M. A., Nyandoro, V. O., Mautsoe, R., Omolo, C. A., & Govender, T. (2026). Uncovering potential targets for MRSA infection treatment: a nanomedicine perspective. Expert Opinion on Therapeutic Targets. https://doi.org/10.1080/14728222.2026.2620600
  7. Ismail, E. A., Nyandoro, V. O., Omolo, C. A., & Govender, T. (2025). Nanocarrier‐Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy. Advanced Healthcare Materials, 2501146. https://doi.org/10.1002/adhm.202501146
  8. Nyandoro, V. O., Peters, X. Q., Omolo, C. A., Gafar, M. A., & Govender, T. (2025). Targeting the ADAM10-Alpha Hemolysin Axis Using Ascorbyl Stearate as a Potential Therapy in S. aureus Infections: In Silico and MST Studies. ACS Omega. https://doi.org/10.1021/acsomega.5c02482
  9. Nyandoro, V. O., Ismail, E. A., Tageldin, A., Gafar, M. A., Peters, X. Q., Mautsoe, R., … Govender, T. (2025). Potential of nanocarrier-mediated delivery of vancomycin for MRSA infections. Expert Opinion on Drug Delivery, 1–19. https://doi.org/10.1080/17425247.2025.2459756
  10. Ismail, E. A., Omolo, C. A., Gafar, M. A., Khan, R., Nyandoro, V. O., Yakubu, E. S., Mackraj, I., Tageldin, A., & Govender, T. (2024). Novel peptide and hyaluronic acid coated biomimetic liposomes for targeting bacterial infections and sepsis. International Journal of Pharmaceutics, 124493. https://doi.org/10.1016/j.ijpharm.2024.124493
  11. Nyandoro, V.O., Masioge, H.K. & Malago, Z.L. Biogenic synthesis of metal nanoparticles: promoting green nanotechnology and sustainable development goals. Clean Techn Environ Policy (2024). https://doi.org/10.1007/s10098-024-02966-0
  12. Tageldin, A., Omolo, C. A., Nyandoro, V. O., Elhassan, E., Kassam, S. Z. F., Peters, X. Q., & Govender, T. (2024). Engineering dynamic covalent bond-based nanosystems for delivery of antimicrobials against bacterial infections. Journal of Controlled Release, 371, 237-257. https://doi.org/10.1016/j.jconrel.2024.05.047
  13. Ismail, E. A., Omolo, C. A., Gafar, M. A., Khan, R., Nyandoro, V. O., Salifu, E. Y., & Govender, T. (2024). Multi-functional pH-responsive and biomimetic chitosan-based nanoplexes for targeted delivery of ciprofloxacin against bacterial sepsis. International Journal of Biological Macromolecules, 130046. https://doi.org/10.1016/j.ijbiomac.2024.130046
  14. Onyancha, J. M., Moriasi, G. A., Meroka, J. O., Wainaina, S. M., Sengera, G. O., & Nyandoro, V. O. (2024). Ethnomedicinal Uses, Phytochemistry, And Pharmacology of the Sarcophyte genus: A Review. Frontiers in Pharmacology, 14, 1301672. https://doi.org/10.3389/fphar.2023.1301672
  15. Nyandoro, V. O., Omolo, C. A., Ismail, E. A., Yong, L., Govender, T. (2023). Inflammation-responsive Drug Delivery Nanosystems for Treatment of Bacterial-induced Sepsis. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2023.123346
  16. Onyancha, J. M., Moriasi, G. A., Nyandoro, V. O., Onyancha, B. M., & Onsinyo, J. M. (2023). Ethnomedicinal review of plants utilized by the Abagusii people of Western Kenya. Advances in Traditional Medicine, 1-31. https://dx.doi.org/10.2139/ssrn.4489756
  17. Vugigi, S., Mshila, C., Nyandoro, V., & Obat, R. (2022). Laboratory Glassware Cleaning Validation by Liquid Chromatographic Quantitation of Betamethasone Valerate Residues. Kabarak Journal of Research & Innovation, 12(2), 66-78. https://doi.org/10.58216/kjri.v12i2.221
  18. Nyandoro, V. O., Ogaji, J. I., & Audu-Peter, J. D. (2020). Influence of electrolyte type, pH, temperature and aging on the viscosity property of okra gum as a suspending agent in paracetamol suspension. Journal of Pharmacy and Bioresources, 8(2): 01-06.
  19. Nyandoro, V. O., & Ogaji, J. I (2019). Effect of particle size of okra gum as suspending agent on some physicochemical properties of reconstituted dry paracetamol suspension. World Journal of Pharmaceutical Research, 8(11): 129-141.
CONFERENCES & INVITED PRESENTATIONS

Conference presentations

  1. Kabarak University School of Pharmacy and International Cancer Institute conference on Advancing Access to Quality Cancer Care and Control (2025).
    • Oral presentation on: An Overview of Market-Approved Novel Delivery Systems for Oncology Therapeutics.
    • Oral presentation on: Dual pathway-targeting Vancomycin-loaded Lipid-Dendrimer hybrid Nanocarrier Therapy for MRSA-induced Sepsis
  2. Annual Academy of Pharmaceutical Sciences South Africa (APSSA) Conference on Converging Skills: From Molecule to Patient Care (2025).
    • Oral presentation on: Dual-targeting Biomimetic Vancomycin-loaded Lipid-Dendrimer hybrid Nanocarrier for Treatment of MRSA-induced Sepsis
  3. 45th Annual Pharmaceutical Society of Kenya Scientific Conference on Beyond the Practice: Pharmacists Innovating for Accessible, Quality & Impactful Healthcare (2025).
    • Oral presentation on: Dual-targeting Biomimetic Vancomycin-loaded Lipid-Dendrimer hybrid Nanocarrier for Treatment of MRSA-induced Sepsis.
  4. College of Health Sciences Annual Research Symposium 2024.
    • Poster presentation on: NLRP3 inflammasome-targeted Ascorbyl Stearate/ Polyethyleneimine Lipid-Dendrimer Hybrid Nanosystem loaded with Vancomycin for MRSA-induced Sepsis
HONORS, PRIZE AND AWARDS
  • 1st prize in the PhD poster category during the University of KwaZulu-Natal College of Health Sciences Annual Symposium 2024. Awarded for exceptional research delivery at the Annual Research Symposium, including an R20,000 travel voucher.
  • Official Letter of Appreciation and Recognition. Formally commended by the Vice-Chancellor for selfless service, executing extra teaching loads across 5 consecutive semesters (2020–2021), and successfully pioneering e-learning systems during the COVID-19 pandemic.
  • Received award for being best overall in pharmacy class of 2016
TEACHING AREAS
  • Research Ethics; Cosmeceuticals and Nutraceuticals; current good manufacturing practices (cGMPs); Pharmaceutical calculations and compounding; Formulation of dosage forms; Pharmaceutical microbiology; Novel drug delivery systems; Biopharmaceutics, bioequivalence & pharmacokinetics; Pharmaceutical biotechnology.
POSTGRADUATE SUPERVISION
Masters Level:
  • Postgraduate students Supervised (Ongoing): [1 Masters’ student]

 

MEMBERSHIP / ASSOCIATION

 1. Registered Pharmacist by the Pharmacy and Poisons Board of Kenya (PPB)

 2. Member of Pharmaceutical Society of Kenya (PSK)

Our Moral Code

As members of Kabarak University family, we purpose at all times and in all places, to set apart in one’s heart, Jesus as Lord. (1 Peter 3:15)